Neuroprotection of low dose carbon monoxide in Parkinson's disease models commensurate with the reduced risk of Parkinson's among smokers
K. N. Rose, Musab M. Zorlu, Aline Fassini, H Lee, Waijiao Cai, X. Xue, Sung‐Han Lin, Pia Kivisäkk, Michael A. Schwarzschild, Xiqun Chen, Stephen N. Gomperts
The paper shows that low-dose carbon monoxide reduces Parkinson's disease pathology in rodent models by activating HO-1, similar to the protective effect observed in smokers.
npj Parkinson s Disease · Aug 22, 2024Peer-reviewedNeuroscience